ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Perfluorocarbon-based Ultrasound Contrast Agents Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-38C17877
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Perfluorocarbon based Ultrasound Contrast Agents Market Research Report 2024
BUY CHAPTERS

Global Perfluorocarbon-based Ultrasound Contrast Agents Market Research Report 2024

Code: QYRE-Auto-38C17877
Report
September 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Major
Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRX Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group

Perfluorocarbon-based Ultrasound Contrast Agents Market

Perfluorocarbon-based ultrasound contrast agents are special types of ultrasound contrast agents. These contrast agents use perfluorocarbons as the gas filler within the microbubbles, and due to their good stability and biocompatibility, they have been widely used in medical imaging fields.
The global Perfluorocarbon-based Ultrasound Contrast Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents include Bracco, GE Healthcare, Lantheus Medical Imaging, ImaRx Therapeutics, Microvascular Therapeutics, Qi-hui Biopharmaceutical, Feiruida Medical, SUNΛ Med-Engineering, Lizhuo Pharmaceutical, Fuman Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Perfluorocarbon-based Ultrasound Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Perfluorocarbon-based Ultrasound Contrast Agents.
The Perfluorocarbon-based Ultrasound Contrast Agents market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Perfluorocarbon-based Ultrasound Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Perfluorocarbon-based Ultrasound Contrast Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Perfluorocarbon-based Ultrasound Contrast Agents Market Report

Report Metric Details
Report Name Perfluorocarbon-based Ultrasound Contrast Agents Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bracco, GE Healthcare, Lantheus Medical Imaging, ImaRx Therapeutics, Microvascular Therapeutics, Qi-hui Biopharmaceutical, Feiruida Medical, SUNΛ Med-Engineering, Lizhuo Pharmaceutical, Fuman Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Perfluorocarbon-based Ultrasound Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Perfluorocarbon-based Ultrasound Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Perfluorocarbon-based Ultrasound Contrast Agents Market report?

Ans: The main players in the Perfluorocarbon-based Ultrasound Contrast Agents Market are Bracco, GE Healthcare, Lantheus Medical Imaging, ImaRx Therapeutics, Microvascular Therapeutics, Qi-hui Biopharmaceutical, Feiruida Medical, SUNΛ Med-Engineering, Lizhuo Pharmaceutical, Fuman Group

What are the Application segmentation covered in the Perfluorocarbon-based Ultrasound Contrast Agents Market report?

Ans: The Applications covered in the Perfluorocarbon-based Ultrasound Contrast Agents Market report are Liver Ultrasonography, Angiographic Ultrasonography, Cardiac Ultrasonography, Others

What are the Type segmentation covered in the Perfluorocarbon-based Ultrasound Contrast Agents Market report?

Ans: The Types covered in the Perfluorocarbon-based Ultrasound Contrast Agents Market report are Sulfur Hexafluoride, Perfluoropropane, Perfluorobutane, Others

Recommended Reports

Ultrasound Imaging Devices

Contrast Agents

Fluorocarbon Chemicals

1 Perfluorocarbon-based Ultrasound Contrast Agents Market Overview
1.1 Product Definition
1.2 Perfluorocarbon-based Ultrasound Contrast Agents by Type
1.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Value Comparison by Type (2024-2030)
1.2.2 Sulfur Hexafluoride
1.2.3 Perfluoropropane
1.2.4 Perfluorobutane
1.2.5 Others
1.3 Perfluorocarbon-based Ultrasound Contrast Agents by Application
1.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Value by Application (2024-2030)
1.3.2 Liver Ultrasonography
1.3.3 Angiographic Ultrasonography
1.3.4 Cardiac Ultrasonography
1.3.5 Others
1.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Estimates and Forecasts
1.4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2019-2030
1.4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales 2019-2030
1.4.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Perfluorocarbon-based Ultrasound Contrast Agents Market Competition by Manufacturers
2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Perfluorocarbon-based Ultrasound Contrast Agents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents, Product Type & Application
2.7 Global Key Manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents, Date of Enter into This Industry
2.8 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Competitive Situation and Trends
2.8.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Perfluorocarbon-based Ultrasound Contrast Agents Players Market Share by Revenue
2.8.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Scenario by Region
3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2019-2030
3.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2019-2024
3.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2025-2030
3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region: 2019-2030
3.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region: 2019-2024
3.3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region: 2025-2030
3.4 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Facts & Figures by Country
3.4.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2019-2030)
3.4.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Facts & Figures by Country
3.5.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2019-2030)
3.5.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Facts & Figures by Region
3.6.1 Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2019-2030)
3.6.3 Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Facts & Figures by Country
3.7.1 Latin America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2019-2030)
3.7.3 Latin America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2019-2030)
4.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2019-2024)
4.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2025-2030)
4.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2019-2030)
4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2019-2030)
4.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2019-2024)
4.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2025-2030)
4.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2019-2030)
4.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2019-2030)
5.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2019-2024)
5.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2025-2030)
5.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2019-2030)
5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2019-2030)
5.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2019-2024)
5.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2025-2030)
5.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2019-2030)
5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bracco
6.1.1 Bracco Company Information
6.1.2 Bracco Description and Business Overview
6.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.1.5 Bracco Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Lantheus Medical Imaging
6.3.1 Lantheus Medical Imaging Company Information
6.3.2 Lantheus Medical Imaging Description and Business Overview
6.3.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.3.5 Lantheus Medical Imaging Recent Developments/Updates
6.4 ImaRx Therapeutics
6.4.1 ImaRx Therapeutics Company Information
6.4.2 ImaRx Therapeutics Description and Business Overview
6.4.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.4.5 ImaRx Therapeutics Recent Developments/Updates
6.5 Microvascular Therapeutics
6.5.1 Microvascular Therapeutics Company Information
6.5.2 Microvascular Therapeutics Description and Business Overview
6.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.5.5 Microvascular Therapeutics Recent Developments/Updates
6.6 Qi-hui Biopharmaceutical
6.6.1 Qi-hui Biopharmaceutical Company Information
6.6.2 Qi-hui Biopharmaceutical Description and Business Overview
6.6.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.6.5 Qi-hui Biopharmaceutical Recent Developments/Updates
6.7 Feiruida Medical
6.7.1 Feiruida Medical Company Information
6.7.2 Feiruida Medical Description and Business Overview
6.7.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.7.5 Feiruida Medical Recent Developments/Updates
6.8 SUNΛ Med-Engineering
6.8.1 SUNΛ Med-Engineering Company Information
6.8.2 SUNΛ Med-Engineering Description and Business Overview
6.8.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.8.5 SUNΛ Med-Engineering Recent Developments/Updates
6.9 Lizhuo Pharmaceutical
6.9.1 Lizhuo Pharmaceutical Company Information
6.9.2 Lizhuo Pharmaceutical Description and Business Overview
6.9.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.9.5 Lizhuo Pharmaceutical Recent Developments/Updates
6.10 Fuman Group
6.10.1 Fuman Group Company Information
6.10.2 Fuman Group Description and Business Overview
6.10.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
6.10.5 Fuman Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Perfluorocarbon-based Ultrasound Contrast Agents Industry Chain Analysis
7.2 Perfluorocarbon-based Ultrasound Contrast Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Perfluorocarbon-based Ultrasound Contrast Agents Production Mode & Process
7.4 Perfluorocarbon-based Ultrasound Contrast Agents Sales and Marketing
7.4.1 Perfluorocarbon-based Ultrasound Contrast Agents Sales Channels
7.4.2 Perfluorocarbon-based Ultrasound Contrast Agents Distributors
7.5 Perfluorocarbon-based Ultrasound Contrast Agents Customers
8 Perfluorocarbon-based Ultrasound Contrast Agents Market Dynamics
8.1 Perfluorocarbon-based Ultrasound Contrast Agents Industry Trends
8.2 Perfluorocarbon-based Ultrasound Contrast Agents Market Drivers
8.3 Perfluorocarbon-based Ultrasound Contrast Agents Market Challenges
8.4 Perfluorocarbon-based Ultrasound Contrast Agents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Major
Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRX Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group
List of Tables
 Table 1. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) of Key Manufacturers (2019-2024)
 Table 5. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Perfluorocarbon-based Ultrasound Contrast Agents Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Perfluorocarbon-based Ultrasound Contrast Agents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents, Product Type & Application
 Table 12. Global Key Manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Perfluorocarbon-based Ultrasound Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perfluorocarbon-based Ultrasound Contrast Agents as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2019-2024) & (Units)
 Table 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2019-2024)
 Table 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2025-2030) & (Units)
 Table 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2025-2030)
 Table 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2019-2024)
 Table 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2025-2030)
 Table 25. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2019-2024) & (Units)
 Table 27. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2025-2030) & (Units)
 Table 28. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2019-2024) & (Units)
 Table 32. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2025-2030) & (Units)
 Table 33. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2019-2024) & (Units)
 Table 37. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2025-2030) & (Units)
 Table 38. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2019-2024) & (Units)
 Table 42. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2025-2030) & (Units)
 Table 43. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2019-2024) & (Units)
 Table 47. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2025-2030) & (Units)
 Table 48. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Type (2019-2024)
 Table 51. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Type (2025-2030)
 Table 52. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2019-2024)
 Table 53. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2025-2030)
 Table 54. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2019-2024)
 Table 57. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2025-2030)
 Table 58. Global Perfluorocarbon-based Ultrasound Contrast Agents Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Perfluorocarbon-based Ultrasound Contrast Agents Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Application (2019-2024)
 Table 61. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units) by Application (2025-2030)
 Table 62. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2019-2024)
 Table 63. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2025-2030)
 Table 64. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2019-2024)
 Table 67. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2025-2030)
 Table 68. Global Perfluorocarbon-based Ultrasound Contrast Agents Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Perfluorocarbon-based Ultrasound Contrast Agents Price (US$/Unit) by Application (2025-2030)
 Table 70. Bracco Company Information
 Table 71. Bracco Description and Business Overview
 Table 72. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 74. Bracco Recent Developments/Updates
 Table 75. GE Healthcare Company Information
 Table 76. GE Healthcare Description and Business Overview
 Table 77. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 79. GE Healthcare Recent Developments/Updates
 Table 80. Lantheus Medical Imaging Company Information
 Table 81. Lantheus Medical Imaging Description and Business Overview
 Table 82. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 84. Lantheus Medical Imaging Recent Developments/Updates
 Table 85. ImaRx Therapeutics Company Information
 Table 86. ImaRx Therapeutics Description and Business Overview
 Table 87. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 89. ImaRx Therapeutics Recent Developments/Updates
 Table 90. Microvascular Therapeutics Company Information
 Table 91. Microvascular Therapeutics Description and Business Overview
 Table 92. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 94. Microvascular Therapeutics Recent Developments/Updates
 Table 95. Qi-hui Biopharmaceutical Company Information
 Table 96. Qi-hui Biopharmaceutical Description and Business Overview
 Table 97. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 99. Qi-hui Biopharmaceutical Recent Developments/Updates
 Table 100. Feiruida Medical Company Information
 Table 101. Feiruida Medical Description and Business Overview
 Table 102. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 104. Feiruida Medical Recent Developments/Updates
 Table 105. SUNΛ Med-Engineering Company Information
 Table 106. SUNΛ Med-Engineering Description and Business Overview
 Table 107. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 109. SUNΛ Med-Engineering Recent Developments/Updates
 Table 110. Lizhuo Pharmaceutical Company Information
 Table 111. Lizhuo Pharmaceutical Description and Business Overview
 Table 112. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 114. Lizhuo Pharmaceutical Recent Developments/Updates
 Table 115. Fuman Group Company Information
 Table 116. Fuman Group Description and Business Overview
 Table 117. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product
 Table 119. Fuman Group Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Perfluorocarbon-based Ultrasound Contrast Agents Distributors List
 Table 123. Perfluorocarbon-based Ultrasound Contrast Agents Customers List
 Table 124. Perfluorocarbon-based Ultrasound Contrast Agents Market Trends
 Table 125. Perfluorocarbon-based Ultrasound Contrast Agents Market Drivers
 Table 126. Perfluorocarbon-based Ultrasound Contrast Agents Market Challenges
 Table 127. Perfluorocarbon-based Ultrasound Contrast Agents Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Perfluorocarbon-based Ultrasound Contrast Agents
 Figure 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Share by Type: 2023 & 2030
 Figure 4. Sulfur Hexafluoride Product Picture
 Figure 5. Perfluoropropane Product Picture
 Figure 6. Perfluorobutane Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Share by Application: 2023 & 2030
 Figure 10. Liver Ultrasonography
 Figure 11. Angiographic Ultrasonography
 Figure 12. Cardiac Ultrasonography
 Figure 13. Others
 Figure 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (2019-2030) & (Units)
 Figure 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price (US$/Unit) & (2019-2030)
 Figure 18. Perfluorocarbon-based Ultrasound Contrast Agents Report Years Considered
 Figure 19. Perfluorocarbon-based Ultrasound Contrast Agents Sales Share by Manufacturers in 2023
 Figure 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Perfluorocarbon-based Ultrasound Contrast Agents Players: Market Share by Revenue in Perfluorocarbon-based Ultrasound Contrast Agents in 2023
 Figure 22. Perfluorocarbon-based Ultrasound Contrast Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2019-2030)
 Figure 25. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2019-2030)
 Figure 26. United States Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2019-2030)
 Figure 29. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2019-2030)
 Figure 37. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Perfluorocarbon-based Ultrasound Contrast Agents by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Perfluorocarbon-based Ultrasound Contrast Agents by Type (2019-2030)
 Figure 56. Global Perfluorocarbon-based Ultrasound Contrast Agents Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Perfluorocarbon-based Ultrasound Contrast Agents by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Perfluorocarbon-based Ultrasound Contrast Agents by Application (2019-2030)
 Figure 59. Global Perfluorocarbon-based Ultrasound Contrast Agents Price (US$/Unit) by Application (2019-2030)
 Figure 60. Perfluorocarbon-based Ultrasound Contrast Agents Value Chain
 Figure 61. Perfluorocarbon-based Ultrasound Contrast Agents Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Microbubbles Ultrasound Contrast Agents Market Research Report 2024
Global High Density Ultrasound Contrast Agent Market Research Report 2025
Global Ultrasonic Microbubble Contrast Agents Market Research Report 2024
Global The Second Generation Ultrasound Contrast Agent Market Research Report 2025
Microbubble Contrast Agents for Ultrasound Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Microbubble Contrast Agent Market Research Report 2024
Global Ultrasound Contrast Agents Market Research Report 2024
Global Lipid Microbubble Ultrasound Contrast Agent Market Research Report 2024
Global Sulfur Hexafluoride SF6 Microbubbles for Injection Market Research Report 2024
Global Contrast Media Contrast Agents Market Research Report 2024
Global Perfluoropropane Albumin Microsphere Injection Market Research Report 2024
Global Freeze dried Microsphere Ultrasound Contrast Agent Market Research Report 2024
Global Fluoropolymer in Healthcare Market Research Report 2024
Global Ultrasonic Contrast Media Market Research Report 2024
Global Contrast Agents Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Medical Contrast Agent Market Insights Forecast to 2030
Global Ophthalmic Perfluorocarbon Liquids Market Research Report 2025
Global Contrast Media Market Research Report 2025
Global Interventional X ray Contrast and Imaging Agents Market Insights Forecast to 2030
Global High Density Contrast Media Market Research Report 2024

RELATED REPORTS

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global ENT Surgery Navigation Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11O6178
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Robotics in Laparoscopic Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7R6277
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Bone Allografts Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9I8785
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions